Nanotechnology-based reformulation of AUY922 mitigates retinal toxicity and retains potent anti-tumor activity

Nanomedicine: Nanotechnology, Biology, and Medicine · Published 2026-05-14 · DOI 10.1016/j.nano.2026.102957

Authors (6)

Chi-Che Hsieh, Nai-Jung Chiang, Sin-Jie Wang, Li-Tzong Chen, Chung-Shi Yang, Che-Hung Shen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Hsieh, C., Chiang, N., Wang, S., et al. (2026). Nanotechnology-based reformulation of AUY922 mitigates retinal toxicity and retains potent anti-tumor activity. Nanomedicine: Nanotechnology, Biology, and Medicine. https://doi.org/10.1016/j.nano.2026.102957

Related articles